# US 2019/0167857 A1 · Biofouling resistant coatings and methods of making and using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167857 A1
- Document ID: US20190167857A1
- Status: Published application
- Kind: A1
- Application number: 16/206,596
- Filed: 2018-11-30
- Published: 2019-06-06
- Earliest claimed: 2017-12-01
- Assignees: The Regents of the University of California; Hydrophilix, LLC
- Inventors: Richard B. Kaner; Dayong Chen; Brian T. McVerry; Ethan Rao; Alexandra L. Polasko
- Web page: https://patentgrep.com/patent/US20190167857A1

## CPC

- A61L 31/10: Macromolecular materials
- A01N 33/00: Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
- A01N 33/12: Quaternary ammonium compounds
- A01N 33/20: containing oxygen or sulfur attached to the carbon skeleton containing the nitro group
- A01N 41/06: Sulfonic acid amides
- A61L 17/005: {containing a biologically active substance, e.g. a medicament or a biocide}
- A61L 17/145: {Coating}
- A61L 27/34: Macromolecular materials
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 29/085: {Macromolecular materials}
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- C08F 220/387: {and containing nitrogen and oxygen}
- C08J 3/245: {Differential crosslinking of one polymer with one crosslinking type, e.g. surface crosslinking}
- C08J 7/0427: {with only one layer of a composition containing a polymer binder (with more layers C08J7/042)}
- C08J 7/056: Forming hydrophilic coatings
- C09D 5/00: Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced {(electrically insulating plastics, resins or waxes H01B3/30)}; Filling pastes
- C09D 133/14: of esters containing halogen, nitrogen, sulfur or oxygen atoms in addition to the carboxy oxygen
- C09D 183/04: Polysiloxanes
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61L 2300/408: Virucides, spermicides
- A61L 2420/02: Methods for coating medical devices
- C08F 2800/10: as molar percentages
- C08F 2810/20: leading to a crosslinking, either explicitly or inherently
- C08J 2383/04: Polysiloxanes
- C08J 2433/14: of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C09D: COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR (cosmetics A61K; processes for applying liquids or other fluent materials to surfaces, in general, B05D; staining wood B27K5/02; glazes or vitreous enamels C03C; natural resins, French polish, drying-oils, driers, turpentine, per se, C09F; polishing compositions other than French polish, ski waxes C09G; adhesives or use of materials as adhesives C09J; materials for sealing or packing joints or covers C09K3/10; materials for stopping leaks C09K3/12; processes for the electrolytic or electrophoretic production of coatings C25D)

## Abstract

Disclosed herein are compositions to use in biofouling-resistant coatings, biofouling-resistant coatings, methods of making biofouling-resistant coatings, biofouling-resistant devices, and methods of making biofouling-resistant devices.

## Claims

### Claim 1

A compound that has the structure of Formula (II):
wherein
each R1a and R1b is independently selected from hydrogen and halogen;
each R2a and R2b is independently selected from halogen, —CN, and optionally substituted C1-C6fluoroalkyl;
each A1, A2, and A3 is independently selected from —C(═O)—, —S(═O)—, —S(═O)2—, and —S(═O)(═NR3c)—;
each B1, B2, and B3 is independently selected from —O— and —NR3c—;
D is —S(═O)2O−, —S(═O)2OR9a, —C(═O)O−, or —C(═O)OR9a;
Z1 is —(CR6cR6d)s—;
Z2 is —(CR6cR6d)t—;
Z3 is —(CR6cR6d)p—;
each R3a and R3c is independently selected from hydrogen, optionally substituted C1-C4 alkyl, and optionally substituted benzyl;
each R3c and R3d is independently selected from hydrogen, optionally substituted C1-C4 alkyl, —X-optionally substituted C1-C4 alkyl, optionally substituted C2-C6 alkenyl, and optionally substituted aryl;
X is —C(═O)—, —S(═O)—, or —S(═O)2—;
each R4c, R4d, R5d, R5e, R6c, and R6d is independently selected from hydrogen, halogen, —CN, —OH, optionally substituted C1-C4 alkyl, optionally substituted C1-C4 fluoroalkyl, optionally substituted C2-C6 alkenyl, —NR3cR3d, —S(═O)2O−, —S(═O)2OR9a, —C(═O)O−, and —C(═O)OR9a;
each R9a, R11a, R11b, R11c, R12a, R12b, and R12c is independently selected from hydrogen, optionally substituted C1-C4 alkyl, and optionally substituted aryl;
n is an integer selected from 0, 1, 2, 3, 4, 5, and 6;
s is an integer selected from 1, 2, 3, 4, or 5;
t is an integer selected from 1, 2, 3, 4, or 5;
p is an integer selected from 1, 2, 3, 4, or 5;
q is an integer selected from 40-60;
r is an integer selected from 1-10; and
wherein the compounds of Formula (II) is charged or zwitterionic.

### Claim 2 (depends on 1)

The compound of claim 1, wherein each R1a and R1b is independently halogen.

### Claim 3 (depends on 1)

The compound of claim 1, wherein each R2a and R2b is independently selected from halogen, —CN, and —CF3.

### Claim 4 (depends on 1)

The compound of claim 1, wherein A1 is —S(═O)2—; A2 is —C(═O)—; and A3 is —C(═O)—.

### Claim 5 (depends on 4)

The compound of claim 4, wherein B1 and B2 are each —NR3c— and wherein B3 is —O—.

### Claim 6 (depends on 5)

The compound of claim 5, wherein D is —S(═O)2O−.

### Claim 7 (depends on 1)

The compound of claim 1, wherein each R6c and R6d is hydrogen and wherein each R3a and R3b is —CH3.

### Claim 8

A compound that has the structure of Formula (III):
wherein
each R1a and R1b is independently selected from hydrogen and halogen;
each R2a and R2b is independently selected from halogen, —CN, and optionally substituted C1-C6fluoroalkyl;
each A1, A2, and A3 is independently selected from —C(═O)—, —S(═O)—, —S(═O)2—, and —S(═O)(═NR3c)—;
each B1, B2, and B3 is independently selected from —O— and —NR3c—;
Z1 is —(CR6cR6d)s—;
Z2 is —(CR6cR6d)t—;
E is —CN, —OR9a, —NR9aR9b, —NR9aR9bR9c+, optionally substituted C1-C4 alkyl, optionally substituted C1-C6fluoroalkyl, —S(═O)2O−, —S(═O)2OR9a, —C(═O)O−, or —C(═O)OR9a;
each R4c, R4d, R5d, R5c, R6c, and R6d is independently selected from hydrogen, halogen, —CN, —OR9a, optionally substituted C1-C4 alkyl, optionally substituted C1-C4 fluoroalkyl, optionally substituted C2-C6 alkenyl, —NR3cR3d, —S(═O)2O−, —S(═O)2OR9a, —C(═O)O−, and —C(═O)OR9a;
each R3c and R3d is independently selected from hydrogen, optionally substituted C1-C4 alkyl, —X-optionally substituted C1-C4 alkyl, optionally substituted C2-C6 alkenyl, and optionally substituted aryl;
X is —C(═O)—, —S(═O)—, or —S(═O)2—;
each R9a, R11a, R11b, R11c, R12a, R12b, and R12c is independently selected from hydrogen, optionally substituted C1-C4 alkyl, and optionally substituted aryl;
n is an integer selected from 0, 1, 2, 3, 4, 5, and 6;
s is an integer selected from 1, 2, 3, 4, or 5;
t is an integer selected from 1, 2, 3, 4, or 5;
q is an integer selected from 40-60; and
r is an integer selected from 1-10.

### Claim 9 (depends on 8)

The compound of claim 8, wherein each R1a and R1b is independently halogen.

### Claim 10 (depends on 8)

The compound of claim 8, wherein each R2a and R2b is independently selected from halogen, —CN, and —CF3.

### Claim 11 (depends on 8)

The compound of claim 8, wherein A1 is —S(═O)2—; A2 is —C(═O)—; and A3 is —C(═O)—.

### Claim 12 (depends on 11)

The compound of claim 11, wherein B1 and B2 are each —NR3c— and wherein B3 is —NR3c—.

### Claim 13 (depends on 12)

The compound of claim 12, wherein E is —NR9aR9bR9c+.

### Claim 14 (depends on 13)

The compound of claim 13, wherein each R9a, R9b, or R9c+ is H or —CH3.

### Claim 15

A medical device coated with a compound that has the structure of Formula (II):
wherein
each R1a and R1b is independently selected from hydrogen and halogen;
each R2a and R2b is independently selected from halogen, —CN, and optionally substituted C1-C6fluoroalkyl;
each A1, A2, and A3 is independently selected from —C(═O)—, —S(═O)—, —S(═O)2—, and —S(═O)(═NR3c)—;
each B1, B2, and B3 is independently selected from —O— and —NR3c—;
D is —S(═O)2O−, —S(═O)2OR9a, —C(═O)O−, or —C(═O)OR9a;
Z1 is —(CR6cR6d)s—;
Z2 is —(CR6cR6d)t—;
Z3 is —(CR6cR6d)p—;
each R3a and R3c is independently selected from hydrogen, optionally substituted C1-C4 alkyl, and optionally substituted benzyl;
each R3c and R3d is independently selected from hydrogen, optionally substituted C1-C4 alkyl, —X-optionally substituted C1-C4 alkyl, optionally substituted C2-C6 alkenyl, and optionally substituted aryl;
X is —C(═O)—, —S(═O)—, or —S(═O)2—;
each R4c, R4d, R5d, R5e, R6c, and R6d is independently selected from hydrogen, halogen, —CN, —OH, optionally substituted C1-C4 alkyl, optionally substituted C1-C4 fluoroalkyl, optionally substituted C2-C6 alkenyl, —NR3cR3d, —S(═O)2O−, —S(═O)2OR9a, —C(═O)O−, and —C(═O)OR9a;
each R9a, R11a, R11b, R11c, R12a, R12b, and R12c is independently selected from hydrogen, optionally substituted C1-C4 alkyl, and optionally substituted aryl;
n is an integer selected from 0, 1, 2, 3, 4, 5, and 6;
s is an integer selected from 1, 2, 3, 4, or 5;
t is an integer selected from 1, 2, 3, 4, or 5;
p is an integer selected from 1, 2, 3, 4, or 5;
q is an integer selected from 40-60;
r is an integer selected from 1-10; and
wherein the compounds of Formula (II) is charged or zwitterionic.

### Claim 16 (depends on 15)

The medical device of claim 15, wherein each R1a and R1b is independently halogen.

### Claim 17 (depends on 15)

The medical device of claim 15, wherein each R2a and R2b is independently selected from halogen, —CN, and —CF3.

### Claim 18 (depends on 15)

The medical device of claim 15, wherein A1 is —S(═O)2—; A2 is —C(═O)—; and A3 is —C(═O)—.

### Claim 19 (depends on 18)

The medical device of claim 18, wherein B1 and B2 are each —NR3c— and wherein B3 is —O—.

### Claim 20 (depends on 19)

The medical device of claim 19, wherein D is —S(═O)2O−.

### Claim 21 (depends on 15)

The medical device of claim 15, wherein each R6c and R6d is hydrogen and wherein each R3a and R3b is —CH3.

### Claim 22 (depends on 15)

The medical device of claim 15, wherein the medical device comprises an implant, an IV, a prosthesis, a suturing material, a valve, a stent, a catheter, a rod, a shunt, a scope, a contact lens, a tubing, a wiring, an electrode, a clip, a fastener, a syringe, a container, or a combination thereof.

### Claim 23

A biofouling-resistant medical device, wherein a surface of the medical device is coated with a phenyl azide-based copolymer that has a number-average molecular weight of between about 10,000 and about 250,000.

### Claim 24 (depends on 23)

The biofouling-resistant medical device of claim 23, wherein the phenyl azide-based copolymer has a number-average molecular weight of between about 10,000 and about 20,000.

### Claim 25 (depends on 23)

The biofouling-resistant medical device of claim 23, wherein the phenyl azide-based copolymer has a polydispersity index (PDI) of between about 1 and about 1.5.

### Claim 26 (depends on 23)

The biofouling-resistant medical device of claim 23, wherein the medical device comprises an implant, an IV, a prosthesis, a suturing material, a valve, a stent, a catheter, a rod, a shunt, a scope, a contact lens, a tubing, a wiring, an electrode, a clip, a fastener, a syringe, a container, or a combination thereof.

### Claim 27 (depends on 26)

The biofouling-resistant medical device of claim 26, wherein the medical device is a catheter.

### Claim 28 (depends on 27)

The biofouling-resistant medical device of claim 27, wherein the catheter is an indwelling catheter.

### Claim 29 (depends on 23)

The biofouling-resistant medical device of claim 23, wherein the copolymer comprises polysulfobetaine.

### Claim 30 (depends on 23)

The biofouling-resistant medical device of claim 23, wherein the biofouling is produced by a bacterium, a virus, and/or a fungus.
